These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1351888)

  • 1. The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study.
    Chan TY; Woo KS; Nicholls MG
    Int J Cardiol; 1992 Jun; 35(3):387-95. PubMed ID: 1351888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G; Johnson ML
    Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
    Rosei EA; Rizzoni D; Comini S; Boari G;
    Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
    J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients.
    Himmelmann A; Hedner T; Snoeck E; Lundgren B; Hedner J
    Eur J Clin Pharmacol; 1996; 51(3-4):259-64. PubMed ID: 9010695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial.
    Van Nueten L; Taylor FR; Robertson JI
    J Hum Hypertens; 1998 Feb; 12(2):135-40. PubMed ID: 9504355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
    Van Nueten L; Lacourcière Y; Vyssoulis G; Korlipara K; Marcadet DM; Dupont AG; Robertson JI
    Am J Ther; 1998 Jul; 5(4):237-43. PubMed ID: 10099065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial.
    Van Nueten L; Rishøj Nielsen M; Vertommen C; Dupont AG; Robertson JI
    Acta Clin Belg; 1999; 54(1):19-25. PubMed ID: 10192973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
    Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihypertensive and cardiac hemodynamic effects of nebivolol.
    DeCrée J; Van Rooy P; Geukens H; Haeverans K; Verhaegen H
    Angiology; 1992 May; 43(5):369-77. PubMed ID: 1348916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients.
    van Merode T; van Bortel LM; Smeets FA; Mooij JM; Bohm RO; Rahn KH; Reneman RS
    J Hypertens Suppl; 1989 Dec; 7(6):S262-3. PubMed ID: 2576665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
    Weiss RJ; Saunders E; Greathouse M
    Clin Ther; 2011 Sep; 33(9):1150-61. PubMed ID: 21864908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
    Lacourcière Y; Lefebvre J; Poirier L; Archambault F; Arnott W
    Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial.
    Van Nueten L; Schelling A; Vertommen C; Dupont AG; Robertson JI
    J Hum Hypertens; 1997 Dec; 11(12):813-9. PubMed ID: 9468009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.